Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medistim Earnings Release 2013

Feb 20, 2014

3662_rns_2014-02-20_ce96d3bb-13df-4e8c-8b9c-31b04e1db3fd.html

Earnings Release

Open in viewer

Opens in your device viewer

4th quarter and preliminary year end financials for 2013 for Medistim ASA

4th quarter and preliminary year end financials for 2013 for Medistim ASA

Medistim delivers record sales for a quarter with

MNOK 52.2 (MNOK 49.7). Sales for 2013 ended at MNOK

191 (MNOK 183.8), which is a 3.9 % growth. Operating

profit (EBIT) for the quarter ended at MNOK 9.0 (MNOK

6.1). Operating profit for 2013 ended at MNOK 35.6

(MNOK 41.1). The Board suggests a dividend of NOK

0.80 per share (MNOK 1.10).